Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer (Q36632306)

From Wikidata
Jump to navigation Jump to search
scientific article published on 5 July 2012
edit
Language Label Description Also known as
English
Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer
scientific article published on 5 July 2012

    Statements

    Topical TLR7 agonist imiquimod can induce immune-mediated rejection of skin metastases in patients with breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit